- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05240105
Evaluation of the "Platform Model" for Staffing in Psychiatric and Psychosomatic Clinics (EPPIK)
Evaluation of the Suitability of the "Platform Model" as an Instrument for Staffing in Psychiatric and Psychosomatic Clinics (EPPIK) - Subproject Psychosomatics
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The aim of the study is to test the suitability of a structural model (so-called platform model) developed by a working group of various scientific societies and professional associations for staffing in psychosomatic medicine and psychotherapy. For this purpose, in three steps (1.) the four treatment clusters developed in the platform model will be quantified and empirically validated on the basis of the therapeutic services provided in health care practice; (2.) the current staffing for the four treatment clusters will be described ("as-is analysis"); and (3.) prototypical therapy plans will be developed as a basis for estimating the target staffing requirements. On this basis, a target staffing estimate will be made for all professional groups.
For the study, a total of 80 psychosomatic clinics from Germany will be randomly selected, belonging in equal parts to the groups of psychosomatic university clinics, psychosomatic specialist hospitals, and psychosomatic departments in somatic or in psychiatric hospitals. In addition, 20 day clinics are included. In these clinics, the structural framework conditions including staffing will be surveyed and the routine documentation of therapy units will be evaluated by cluster analysis in order to empirically validate the presumed treatment clusters and to describe the necessary staffing requirements.
The empirical examination and validation of the platform model, including the four assumed treatment clusters, has the potential to positively influence care practice in the long term by adjusting staffing levels in psychosomatic clinics to actual care requirements.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: Simone U Jennissen, PhD
- Phone Number: 004962215634620
- Email: simone.jennissen@med.uni-heidelberg.de
Study Locations
-
-
Baden-Württemberg
-
Heidelberg, Baden-Württemberg, Germany, 69120
- Recruiting
- Simone University Jennissen
-
Contact:
- Simone U Jennissen, PhD
- Phone Number: +4962215634620
- Email: simone.jennissen@med.uni-heidelberg.de
-
Contact:
- Hans-Christoph Friederich, Prof.
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria for Clinics:
- belong to the predefined nationwide population of psychosomatic specialist clinics and departments
- randomly selected for inclusion in the study,
- the clinic management (head physician or comparable) agrees to participation in the study
- possibility of electronic recording of the qualified therapy units for all treating professional groups.
Inclusion Criteria for Patients:
- patient treated in one of the selected clinics on the corresponding ward or day clinic
- at least 18 years old
Exclusion Criteria:
- none
Study Plan
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Departments for Psychosomatic Medicine at University Clinics
no study interventions, observational group
|
There will be no interventions.
The study is purely observational and investigates differences in naturally occuring treatments at these four types of departments for Psychosomatic Medicine.
|
Clinics specialized in Psychosomatic Medicine
no study interventions, observational group
|
There will be no interventions.
The study is purely observational and investigates differences in naturally occuring treatments at these four types of departments for Psychosomatic Medicine.
|
Departments for Psychosomatic Medicine at general hospitals
no study interventions, observational group
|
There will be no interventions.
The study is purely observational and investigates differences in naturally occuring treatments at these four types of departments for Psychosomatic Medicine.
|
Departments for Psychosomatic Medicine at psychiatric hospitals
no study interventions, observational group
|
There will be no interventions.
The study is purely observational and investigates differences in naturally occuring treatments at these four types of departments for Psychosomatic Medicine.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Administered Treatments
Time Frame: Week one of treatment: assessment of administered treatment units
|
units of psychotherapeutic treatment administered to each patient by physicians, psychologists, nurses, art therapists, social workers, and physiotherapists
|
Week one of treatment: assessment of administered treatment units
|
Administered Treatments
Time Frame: Week two of treatment: assessment of administered treatment units
|
units of psychotherapeutic treatment administered to each patient by physicians, psychologists, nurses, art therapists, social workers, and physiotherapists
|
Week two of treatment: assessment of administered treatment units
|
Administered Treatments
Time Frame: Week three of treatment: assessment of administered treatment units
|
units of psychotherapeutic treatment administered to each patient by physicians, psychologists, nurses, art therapists, social workers, and physiotherapists
|
Week three of treatment: assessment of administered treatment units
|
Administered Treatments
Time Frame: Week four of treatment: assessment of administered treatment units
|
units of psychotherapeutic treatment administered to each patient by physicians, psychologists, nurses, art therapists, social workers, and physiotherapists
|
Week four of treatment: assessment of administered treatment units
|
Administered Treatments
Time Frame: Week five of treatment: assessment of administered treatment units
|
units of psychotherapeutic treatment administered to each patient by physicians, psychologists, nurses, art therapists, social workers, and physiotherapists
|
Week five of treatment: assessment of administered treatment units
|
Administered Treatments
Time Frame: Week six of treatment: assessment of administered treatment units
|
units of psychotherapeutic treatment administered to each patient by physicians, psychologists, nurses, art therapists, social workers, and physiotherapists
|
Week six of treatment: assessment of administered treatment units
|
Administered Treatments
Time Frame: Week seven of treatment: assessment of administered treatment units
|
units of psychotherapeutic treatment administered to each patient by physicians, psychologists, nurses, art therapists, social workers, and physiotherapists
|
Week seven of treatment: assessment of administered treatment units
|
Administered Treatments
Time Frame: Week eight of treatment: assessment of administered treatment units
|
units of psychotherapeutic treatment administered to each patient by physicians, psychologists, nurses, art therapists, social workers, and physiotherapists
|
Week eight of treatment: assessment of administered treatment units
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
HONOS - Health of the Nation Outcome Scales
Time Frame: administered once per patient at week one of treatment
|
measure of severity of mental illness
|
administered once per patient at week one of treatment
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- EPPIK
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Psychosomatic Medicine
-
Hannover Medical SchoolUnknownLung Transplantation | Psychosomatic Medicine
-
Yonggui YuanNot yet recruitingWell-Being, Psychological | Psychosomatic; Disorder, Multiple
-
Radboud University Medical CenterCompletedMedically Unexplained Symptoms | Psychosomatic TherapyNetherlands
-
Center for Primary Care and Public Health (Unisante)...University of Lausanne Hospitals; Neuchâtel Psychiatry Centre (CNP)Not yet recruitingQuality of Life | Mental Health Issue | Collaboration | Psychosomatic Disorders | Doctor-Patient Relation | Depression/Anxiety | Patients Lived ExperiencesSwitzerland
-
Hannover Medical SchoolTerminatedDepression | Schizophrenia | Anxiety Disorders | Dementia | Psychosomatic DisordersGermany
-
Hannover Medical SchoolInstitut für Arzneimittelsicherheit in der Psychiatrie AMSP e.V.; Asklepios... and other collaboratorsUnknownDepression | Schizophrenia | Anxiety Disorders | Dementia | Psychosomatic DisordersGermany
-
Institut et Haute Ecole de la Santé la SourceHEIG-VD- Haute Ecole d'Ingénierie et de Gestion du Canton de VaudCompletedPreventative MedicineSwitzerland
-
University of TartuCompleted
-
University Hospital, GrenobleCompleted
-
NYU Langone HealthCompletedPhysical MedicineUnited States
Clinical Trials on no intervention, purely observational
-
Aalborg University HospitalNordsimWithdrawnColorectal CancerDenmark
-
University of Colorado, DenverNational Institute on Drug Abuse (NIDA)CompletedThe Influence of in Utero Cannabis Exposure on Neonatal Brain Morphology and Structural ConnectivityDrug Use | Neurodevelopmental Abnormality | Cannabis Use Disorder | PREG1 | Fetal Exposure During PregnancyUnited States
-
Cardiff and Vale University Health BoardCompleted
-
Centre Hospitalier Universitaire de NīmesNot yet recruitingCalcified Cerebral EmbolismFrance
-
Centre Hospitalier Universitaire de NīmesRecruitingAcute Cerebral and Cerebellar Cortical Microinfarctions (CMI)France
-
University of MinnesotaCompletedIschemic Stroke | MCA InfarctionUnited States
-
Hospital Universitario La Paz3MVX CCB and Agaplesion Markus Krankenhaus, Frankfurt a.M., Germany.; Department...RecruitingEmbolism | Atrial Fibrillation | Arrhythmia | Stroke, Acute | Stroke Sequelae | AblationSpain
-
Hôpital Necker-Enfants MaladesUnknown
-
University Hospital, Basel, SwitzerlandCompletedPostoperative Complications | Intraoperative Complications | Patient Safety | Risk ManagementNew Zealand, Switzerland, United States, Netherlands, Spain, Austria, Turkey, United Kingdom, Australia, Greece, Ireland, Italy